Skip to main content

Molecular Cytogenetic Stratification of Renal Cell Tumors

  • Conference paper
Biology of Renal Cell Carcinoma
  • 43 Accesses

Abstract

The incidence of renal cell carcinoma in the population is 5–10 per 100,000. There is no satisfactory screening method for early detection. About 40% of the patients have metastatic disease at the time of diagnosis and one-third of the remainder will develop distant metastases during the postoperative course. The most effective therapy for RCC localized to the kidney is surgery, whereas a metastatic tumor is practically incurable. The overall response to biological response modifiers is low and the treatment is only palliative in the vast majority of cases. The goal of future therapy is to target specific tumor suppressor genes and other tumor-related genes. Therefore, it is important that genetics be incorporated into the evaluation of renal cell neoplasms in an attempt to provide a foundation for an appropriate diagnosis and selective treatment.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Kovacs G. Molecular differential pathology of renal cell tumors. Histopathology 22: 1–8, 1993.

    Article  PubMed  CAS  Google Scholar 

  2. Ishikawa I, Kovacs G. High incidence of papillary renal cell tumours in patients on chronic haemodialysis. Histopathology 22: 135–139, 1993.

    Article  PubMed  CAS  Google Scholar 

  3. Zbar B, Tory K, Merino M, et al. Hereditary papillary renal cell carcinoma. J Urol 151: 561–566, 1994.

    PubMed  CAS  Google Scholar 

  4. Kovacs G, Papillary renal cell carcinoma: a morphologic and cytogenetic study of 11 cases. Am J Pathol 134: 27–34, 1989.

    PubMed  CAS  Google Scholar 

  5. Behrens J, Mareel MM, VanRoy FM, Birchmeyer W. Dissecting tumor cell invasion: epithelial cells acquire invasive properties after the loss of uvomorulin-mediated cel-cell adhesion. J Cell Biol 108: 2435–41, 1989.

    Article  PubMed  CAS  Google Scholar 

  6. Sato T, Akiyama F, Sakamoto G, Kasumi F, Nakamura Y. Accumulation of genetic alterations and progression of primary breast cancer. Cancer Res 51: 5794–5799, 1991.

    PubMed  CAS  Google Scholar 

  7. Kovacs G, Fuzesi L, Emanuel A, Kung H. Cytogenetics of papillary renal cell carcinomas. Genes Chromosomes and Cancer 3: 249–255, 1991.

    Article  PubMed  CAS  Google Scholar 

  8. Kovacs G, Kovacs A. Parenchymal lesions associated with the development of papillary renal cell tumors. J Urol Pathol 1: 301–311, 1993.

    Google Scholar 

  9. Meloni AM, Dobbs RM, Pontes JE, Sandberg AA. Translocation (X;1) in papillary renal cell carcinoma: A new cytogenetic subtype. Cancer Genet Cytogenet 65: 1–6, 1993.

    Article  PubMed  CAS  Google Scholar 

  10. Kovacs G. Molecular cytogenetics of renal cell tumors. Adv Cancer Res 62: 89–124, 1993.

    Article  PubMed  CAS  Google Scholar 

  11. Li FP, Marchetto DJ, Brown RS. Familial renal cell carcinoma. Cancer Genet Cytogenet 7: 271–273, 1982.

    Article  PubMed  CAS  Google Scholar 

  12. Cohen AJ, Li FP, Berg S, et al. Hereditary renal cell carcinoma associated with a chromosomal translocation. New Engi J Med 301: 592–595, 1982.

    Article  Google Scholar 

  13. Kovacs G, Brusa P, DeRiese W. Tissue specific expression of a constitutional 3;6 translocation: development of multiple bilateral renal cell carcinomas. Int J Cancer 43: 422–427, 1989.

    Article  PubMed  CAS  Google Scholar 

  14. Lamiell JM, Sabarar FG, Hsia YE. Von Hippel-Lindau disease. Affecting 43 members of a single kindred. Medicine (Baltimore) 68: 1–29, 1989.

    CAS  Google Scholar 

  15. Solomon D, Schwartz A. Renal pathology in von Hippel-Lindau disease. Hum Pathol 19: 1072–1079, 1988.

    Article  PubMed  CAS  Google Scholar 

  16. Latif F, Tory K, Gnarra J, et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260: 1317–1320, 1993.

    Article  PubMed  CAS  Google Scholar 

  17. Gnarra JR, Tory K, Weng Y, et al. Mutations of the VHL tumour suppressor gene in renal carcinoma. Nature Genetics 7: 85–90, 1994.

    Article  PubMed  CAS  Google Scholar 

  18. Kovacs G, Kung H. Non-homologous chromatid exchange in hereditary and sporadic renal cell carcinomas. Proc Natl Acad Sci USA 88: 194–198, 1991.

    Article  PubMed  CAS  Google Scholar 

  19. Kovacs G, Emanuel A, Neumann HPH, Kung H. Cytogenetics of renal cell carcinomas asociated with von Hippel-Lindau disease. Genes Chromosomes Cancer 3: 256–262, 1991.

    Article  PubMed  CAS  Google Scholar 

  20. Kovacs G, Erlandsson R, Boldog F, et al. Consistent 3p deletion and loss of heterozygosity in renal cell carcinoma. Proc Natl Acad Sci USA 85: 1571–1575, 1988.

    Article  PubMed  CAS  Google Scholar 

  21. Kovacs G, Frisch S. Clonal chromosome abnormalities in tumor cells from patients with sporadic renal cell carcinomas. Cancer Res 49: 651–659, 1989.

    PubMed  CAS  Google Scholar 

  22. Zbar B, Brauch H, Talmadge C, Linehan M. Loss of alleles of loci on theshort arm of chromosome 3 in renal cell carcinoma. Nature 327: 721–724, 1987.

    Article  PubMed  CAS  Google Scholar 

  23. Reiter RE, Anglard P, Liu S, Gnarra JR, Linehan WM. Chromosome 17p deletions and p53 mutations in renal cell carcinoma. Cancer Res 53: 3092–3095, 1993.

    PubMed  CAS  Google Scholar 

  24. Thoenes W, Storkel S, Rumpelt HF, et al. Chromophobe renal cell carcinoma and its variants–report on 32 cases. J Pathol 155: 125–143, 1988.

    Article  Google Scholar 

  25. Kovacs A, Kovacs G. Low chromosome number in chromophobe renal cell carcinomas. Genes Chromosomes and Cancer 4: 267–268, 1992.

    Article  PubMed  CAS  Google Scholar 

  26. Speicher M, Scholl B, Manoir S, et al. Loss of chromosomes 1, 2, 6, 10, 13, 17 and 21 in chromophobe renal cell carcinomas revealed by comparative genomic hybridisation. Am J Pathol (in press)

    Google Scholar 

  27. Kovacs A, Storkel S, Thoenes W, Kovacs G. Mitochondrial and chromosomal DNA alterations in human chromophobe renal cell carcinomas. J Pathol 167: 273–277, 1992.

    Article  PubMed  CAS  Google Scholar 

  28. Kovacs G, Welter C, Wilkens L, Blin N, DeRiese W. Renal oncocytoma–a phenotypic and genetic entity of renal parenchymal tumors. Am J Pathol 134: 967–971, 1989.

    PubMed  CAS  Google Scholar 

  29. Presti JC, Rao PH, Reuter VE, et al. Histopathological, cytogenetic and molecular characterisation of renal cortical tumors. Cancer Res 51: 1544–1552, 1991

    PubMed  Google Scholar 

  30. Crotty TB, Lawrence KM, Moertel CA, et al. Cytogenetic analysis of six renal oncocytomas and a chromophobe renal cell carcinoma: Evidence that–Y,–1 may be the characteristic anomaly in renal oncocytomas. Cancer Genet Cytogenet 61: 61–66, 1992.

    Article  PubMed  CAS  Google Scholar 

  31. Kovacs G, Wilkens L, Papp T, DeRiese W. Differentiation between papillary and nonpapillary renal cell carcinomas by DNA analysis. J Natl Cancer Inst 81: 527–530, 1989.

    Article  PubMed  CAS  Google Scholar 

  32. Novick AC, Streem S, Montie JE, et al. Conservative surgery for renal cell carcinoma: single-center experience with 100 patients. J Urol 141: 835–839, 1989.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

Copyright information

© 1995 Springer-Verlag New York Inc.

About this paper

Cite this paper

Kovacs, G. (1995). Molecular Cytogenetic Stratification of Renal Cell Tumors. In: Biology of Renal Cell Carcinoma. Springer, New York, NY. https://doi.org/10.1007/978-1-4612-2536-2_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-4612-2536-2_2

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4612-7571-8

  • Online ISBN: 978-1-4612-2536-2

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics